BDBM63212 3-(acetylamino)-N-(2-furylmethyl)-N-methyl-4-[(4-methylphenyl)thio]benzamide::3-acetamido-N-(2-furanylmethyl)-N-methyl-4-[(4-methylphenyl)thio]benzamide::3-acetamido-N-(2-furfuryl)-N-methyl-4-(p-tolylthio)benzamide::3-acetamido-N-(furan-2-ylmethyl)-N-methyl-4-(4-methylphenyl)sulfanyl-benzamide::3-acetamido-N-(furan-2-ylmethyl)-N-methyl-4-(4-methylphenyl)sulfanylbenzamide::MLS000584433::SMR000207019::cid_4304122

SMILES Cc1cccc(-c2nn(CC(=O)Nc3cc(F)cc(C(=O)O[C@@H]4CN5CCC4CC5)c3)cc2-c2ccnc3ccccc23)n1

InChI Key InChIKey=PFXDDWPTEWECAD-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 63212   

TargetTGF-beta receptor type-1(Human)
Agomab Spain S.L.U.

US Patent
LigandChemical structure of BindingDB Monomer ID 63212BDBM63212((R)-quinuclidin-3-yl 3-fluoro-5-(2-(3-(6-methylpyr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent